S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Concentrix Faces Shareholder Investigation After Revenue Outlook Cut

A sharp 20% overnight plunge in Concentrix stock has triggered an investigation by the law firm Levi & Korsinsky. The inquiry centers on whether company officers provided misleading financial guidance to investors regarding 2026 revenue expectations, potentially violating securities laws after the firm drastically lowered its annual projections.

Concentrix Faces Shareholder Investigation After Revenue Outlook Cut
Photo: Bio & News

The investigation follows a sudden reversal in market expectations for the NASDAQ-listed company. Prior to June 30, 2026, Concentrix management had assured stakeholders that annual revenue would reach at least $10.035 billion, with non-GAAP operating income projected at $1.24 billion. These targets were abandoned during the company’s second-quarter earnings report, where new guidance capped revenue at $10.025 billion and operating income at $1.23 billion.

Levi & Korsinsky, a firm frequently cited in the ISS Securities Class Action Services' Top 50, is now evaluating whether those earlier forecasts constituted materially false or misleading statements. Investors who purchased shares and incurred losses are encouraged to provide documentation for a legal evaluation. The firm emphasizes that participation in the investigation does not require court appearances or upfront legal fees, as cases of this nature typically operate on a contingency basis.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!